Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes

Objective. Genital herpes (GH) recurrences and viral shedding are more frequent in the first year after initial HSV-2 infection. The objective of this study was to provide the first evaluation of valacyclovir 1 g once daily compared to placebo in reducing viral shedding in subjects newly diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Mark G., Fife, Kenneth H., Leone, Peter A., Dix, Lynn P., Brennan, Clare A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724712/
https://www.ncbi.nlm.nih.gov/pubmed/19680456
http://dx.doi.org/10.1155/2009/105376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724712/
https://www.ncbi.nlm.nih.gov/pubmed/19680456
http://dx.doi.org/10.1155/2009/105376

Ejemplares similares